Perjeta infusion 420mg injection

Perjeta 420mg (pertuzumab) is a prescription medication that is classified as an anticancer targeted drug used to treat patients with HER2 positive breast cancer. It is given through the intravenous method, where it binds to HER2 receptor protein in the cancer cells, thus inhibiting the pathways that lead to the growth of the tumors.It is usually given together with Herceptin and chemotherapyKey InformationActive ingredient: Pertuzumab.Brand Manufacturer: Roche.Disease(s) treated with Perjeta: HER2 Positive Metastatic Breast Cancer, and Early Stage HER2 Positive Breast Cancer Mechanism of action: While Herceptin blocks the HER2 receptors, Perjeta binds to another site of the HER2 receptors thus stopping its association (dimerization) with other HER proteins.